{"schema_version":"secwatch.filing_event.v1","accession":"0001903596-26-000287","form_type":"8-K","ticker":null,"cik":"0001497130","company_name":"Nano Mobile Healthcare, Inc.","filed_at":"2026-08-03T20:48:51+00:00","discovered_at":"2026-08-03T20:50:16.407925+00:00","generated_at":"2026-08-03T20:50:23.476810+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nano Mobile Healthcare to acquire Neptune Engineering in stock-for-stock deal; new leadership appointed","bullets":["Acquires Neptune Engineering (Marine) Ltd, a Hong Kong marine and diving engineering contractor, for 20M shares of VNTH common stock.","Neptune shareholders receive 20M shares (post-restructuring) for 100% of Neptune; Neptune becomes wholly-owned subsidiary.","New directors: Cheng Chung Sing (Chairman), Cheng Chung Yu (CEO), Angel Yik (CFO); Roy Watson remains President.","Neptune's FY2025 revenue HK$9.07M (~$1.16M), net profit HK$862,586 (~$110K); unsecured loans HK$4.04M.","Closing expected on third business day after conditions satisfied; shares restricted under Regulation S."],"urls":{"canonical":"https://secwatch.observer/filing/0001903596-26-000287","json":"https://secwatch.observer/filing/0001903596-26-000287.json","markdown":"https://secwatch.observer/filing/0001903596-26-000287.md","text":"https://secwatch.observer/filing/0001903596-26-000287.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1497130/000190359626000287/0001903596-26-000287-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1497130/000190359626000287/vnth_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T20:50:23.476810+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7b7dbcef7f","claim":"Angel Yik was elected as Director and Secretary, as Chief Financial Officer (CFO) at Nano Mobile Healthcare, Inc..","evidence_excerpt":"Angel Yik as Director and Secretary, as Chief Financial Officer (CFO)","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497130/000190359626000287/0001903596-26-000287-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director and Secretary, as Chief Financial Officer (CFO)"}],"fact_type":"executive_change"},{"claim_id":"de8ed1bb46","claim":"Cheng Chung Yu was elected as Director and Chief Executive Officer at Nano Mobile Healthcare, Inc..","evidence_excerpt":"Cheng Chung Yu (Neptune (HK)) as Director and Chief Executive Officer CEO","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497130/000190359626000287/0001903596-26-000287-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"fe1cce69a1","claim":"Cheng Chung Sing was elected as Director, Chairman of the Board at Nano Mobile Healthcare, Inc..","evidence_excerpt":"Cheng Chung Sing (Byron) as Director, Chairman of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497130/000190359626000287/0001903596-26-000287-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director, Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}